What are GLP-1 drugs and why have they become so central to Lilly’s business?
Replied byDave Ricks
Chair & CEO at Eli Lilly and Company
Niche: Pharmaceuticals, AI, Health & Wellness
Revenue: $1M+/month
Location: USA
Started: 2015 or earlier
GLP-1 drugs began as diabetes treatments and proved powerful for weight loss. They act on brain and gut pathways for appetite, glucose, and energy. For many people they bring sustained double-digit weight loss with health benefits, so demand exploded. Our job is to scale factories, supply chains, and long-term evidence to match that responsibility.
0
From the Full Interview
This answer is part of a full interview with Dave Ricks, Chair & CEO at Eli Lilly and Company.
Share this Answer
Found this insight valuable? Share it with your network to help others learn from Dave Ricks's experience.
Related Answers
No related answers found.